Antibody-based therapies have evolved beyond monoclonal antibodies (mAbs) to include bispecific antibodies, antibody fragments, antibody-drug conjugates (ADCs), and more novel therapeutics. These molecules share some common unit operations. Learn about them by clicking on the hotspots in the link above.
